RA CAPITAL MANAGEMENT, L.P. Q4 2020 Filing
Filed February 16, 2021
Portfolio Value
$7.2T
Holdings
82
Report Date
Q4 2020
Filing Type
13F-HR
All Holdings (82 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDASCENDIS PHARMA A S | 5,865,338 | $978.2B | 13.67% | |
| 2 | TGTXTG THERAPEUTICS INC | 8,685,471 | $451.8B | 6.32% | |
| 3 | NVV1NOVAVAX INC | 3,788,564 | $422.5B | 5.91% | |
| 4 | NKTXNKARTA INC | 5,605,129 | $344.5B | 4.82% | |
| 5 | —FORMA THERAPEUTICS HLDGS INC | 9,011,651 | $314.5B | 4.40% | |
| 6 | ARVNARVINAS INC | 3,672,872 | $311.9B | 4.36% | |
| 7 | CCXIEURCHEMOCENTRYX INC | 4,776,548 | $295.8B | 4.13% | |
| 8 | AVIRATEA PHARMACEUTICALS INC | 5,368,451 | $224.3B | 3.14% | |
| 9 | 5E7ITEOS THERAPEUTICS INC | 4,417,258 | $149.4B | 2.09% | |
| 10 | —KINNATE BIOPHARMA INC | 3,593,052 | $142.9B | 2.00% | |
| 11 | AXSMAXSOME THERAPEUTICS INC | 1,655,447 | $134.9B | 1.89% | |
| 12 | KROSKEROS THERAPEUTICS INC | 1,875,000 | $132.3B | 1.85% | |
| 13 | PHATPHATHOM PHARMACEUTICALS INC | 3,825,008 | $127.1B | 1.78% | |
| 14 | RYTMRHYTHM PHARMACEUTICALS INC | 4,179,067 | $124.2B | 1.74% | |
| 15 | TVTXTRAVERE THERAPEUTICS INC | 4,557,867 | $124.2B | 1.74% | |
| 16 | IMGNEURIMMUNOGEN INC | 18,417,458 | $118.8B | 1.66% | |
| 17 | RCKTROCKET PHARMACEUTICALS INC COM | 2,136,081 | $117.1B | 1.64% | |
| 18 | ETNBGBP89BIO INC | 4,736,214 | $115.4B | 1.61% | |
| 19 | —ZOGENIX INC | 5,345,631 | $106.9B | 1.49% | |
| 20 | PMVPPMV PHARMACEUTICALS INC | 1,710,265 | $105.2B | 1.47% | |
| 21 | OLMAOLEMA PHARMACEUTICALS INC | 2,150,404 | $103.4B | 1.45% | |
| 22 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 9,502,383 | $103.0B | 1.44% | |
| 23 | MGNXMACROGENICS INC | 4,375,217 | $100.0B | 1.40% | |
| 24 | PCVXVAXCYTE INC | 3,710,699 | $98.6B | 1.38% | |
| 25 | 1K0IGM BIOSCIENCES INC | 982,723 | $86.8B | 1.21% | |
| 26 | BDTXBLACK DIAMOND THERAPEUTICS INC | 2,589,904 | $83.0B | 1.16% | |
| 27 | SPRYSILVERBACK THERAPEUTICS INC | 1,742,186 | $80.7B | 1.13% | |
| 28 | TREURTRILLIUM THERAPEUTICS INC | 5,290,481 | $77.8B | 1.09% | |
| 29 | SLDBSOLID BIOSCIENCES INC | 9,976,569 | $75.6B | 1.06% | |
| 30 | KALAKALA PHARMACEUTICALS INC | 10,874,613 | $73.7B | 1.03% | |
| 31 | —FIVE PRIME THERAPEUTICS INC | 4,285,161 | $72.9B | 1.02% | |
| 32 | INBXUSDINHIBRX INC | 2,129,003 | $70.2B | 0.98% | |
| 33 | LEGNLEGEND BIOTECH CORP | 2,408,292 | $67.8B | 0.95% | |
| 34 | —CURIS INC | 7,707,790 | $63.1B | 0.88% | |
| 35 | WVEWAVE LIFE SCIENCES LTD | 7,775,207 | $61.2B | 0.86% | |
| 36 | CRDFCARDIFF ONCOLOGY INC | 3,290,000 | $59.2B | 0.83% | |
| 37 | DYNDYNE THERAPEUTICS INC | 2,805,045 | $58.9B | 0.82% | |
| 38 | —CONSTELLATION PHARMCETICLS INC | 1,852,746 | $53.4B | 0.75% | |
| 39 | PACBPACIFIC BIOSCIENCES OF CALIFORNIA INC | 1,987,997 | $51.6B | 0.72% | |
| 40 | GONGERON CORP | 30,126,299 | $47.9B | 0.67% | |
| 41 | STROSUTRO BIOPHARMA INC | 2,118,212 | $46.0B | 0.64% | |
| 42 | CCCCC4 THERAPEUTICS INC | 1,377,569 | $45.6B | 0.64% | |
| 43 | —AKOUOS INC | 2,281,249 | $45.2B | 0.63% | |
| 44 | RLAYRELAY THERAPEUTICS INC | 1,000,000 | $41.6B | 0.58% | |
| 45 | INZYINOZYME PHARMA INC | 2,003,653 | $41.4B | 0.58% | |
| 46 | ORTXUSDORCHARD THERAPEUTICS PLC | 12,315,213 | $41.2B | 0.58% | |
| 47 | ARDXARDELYX INC | 6,163,086 | $39.9B | 0.56% | |
| 48 | CERE1EURCEREVEL THERAPEUTICS HLDNG INC | 2,200,000 | $36.5B | 0.51% | |
| 49 | ARQTARCUTIS BIOTHERAPEUTICS INC | 1,165,184 | $32.8B | 0.46% | |
| 50 | LRMRLARIMAR THERAPEUTICS INC | 1,515,151 | $32.4B | 0.45% | |
| 51 | VRNAVERONA PHARMA PLC | 5,100,000 | $31.8B | 0.44% | |
| 52 | —PANDION THERAPEUTICS INC | 1,770,023 | $26.3B | 0.37% | |
| 53 | ALECALECTOR INC | 1,616,879 | $24.5B | 0.34% | |
| 54 | CNCEEURCONCERT PHARMACEUTICALS INC | 1,823,520 | $23.0B | 0.32% | |
| 55 | SNDXSYNDAX PHARMACEUTICALS INC | 1,023,067 | $22.8B | 0.32% | |
| 56 | —SATSUMA PHARMACEUTICALS INC | 4,681,858 | $21.6B | 0.30% | |
| 57 | ORICORIC PHARMACEUTICALS INC | 584,000 | $19.8B | 0.28% | |
| 58 | SCPHSCPHARMACEUTICALS INC | 3,518,998 | $18.6B | 0.26% | |
| 59 | MRNS*MARINUS PHARMACEUTICALS INC | 1,300,000 | $15.9B | 0.22% | |
| 60 | VXRTVAXART INC | 2,742,271 | $15.7B | 0.22% | |
| 61 | MISTMILESTONE PHARMACEUTICALS INC | 2,327,714 | $15.6B | 0.22% | |
| 62 | OCULOCULAR THERAPEUTIX INC | 750,000 | $15.5B | 0.22% | |
| 63 | —BCTG ACQUISITION CORP | 1,250,000 | $14.3B | 0.20% | |
| 64 | RPTXREPARE THERAPEUTICS INC | 409,000 | $14.0B | 0.20% | |
| 65 | —BCLS ACQUISITION CORP | 1,250,000 | $13.9B | 0.19% | |
| 66 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 2,499,025 | $13.5B | 0.19% | |
| 67 | COGTCOGENT BIOSCIENCES INC | 1,025,641 | $11.5B | 0.16% | |
| 68 | —ARYA SCIENCES ACQUISITION CO | 1,000,000 | $10.8B | 0.15% | |
| 69 | —FRAZIER LIFESCIENCES ACQUISITION CO | 1,000,000 | $10.4B | 0.15% | |
| 70 | —THERAPEUTICSMD INC | 7,812,500 | $9.5B | 0.13% | |
| 71 | LYRALYRA THERAPEUTICS INC | 815,849 | $9.3B | 0.13% | |
| 72 | PASGPASSAGE BIO INC | 322,630 | $8.3B | 0.12% | |
| 73 | —HEALTH SCIENCES ACQ CORP 2 | 625,000 | $8.0B | 0.11% | |
| 74 | MLTXHELIX ACQUISITION CORP | 700,000 | $8.0B | 0.11% | |
| 75 | CRNXCRINETICS PHARMACEUTICALS INC | 564,102 | $8.0B | 0.11% | |
| 76 | —5 01 ACQUISITION CORP | 750,000 | $7.6B | 0.11% | |
| 77 | —MIRAGEN THERAPEUTICS INC | 451,932 | $7.4B | 0.10% | |
| 78 | —IMARA INC | 248,804 | $5.5B | 0.08% | |
| 79 | PRNPROFOUND MEDICAL CORP | 192,311 | $4.0B | 0.06% | |
| 80 | ASNSUSDX4 PHARMACEUTICALS INC | 536,962 | $3.5B | 0.05% | |
| 81 | —CEREVEL THERAPEUTICS HLDNG INC | 233,333 | $1.3B | 0.02% | |
| 82 | OVIDOVID THERAPEUTICS INC | 285,000 | $658.0M | 0.01% |